Ovarian cancer information for commissioners

Learn about our transformational project, 'Breaking down barriers to early diagnosis', and explore how you can help reduce regional variation in the early diagnosis of ovarian cancer.

We’re undertaking groundbreaking work to reduce regional inequalities in early diagnosis. This involves working directly with primary care systems to develop and test innovative interventions that will break down barriers to diagnosis. This project and its outcomes will be reinforcing the NHS long term plan aim of 75 per cent of cancers being diagnosed at stages I and II by 2028. 

Our work is being undertaken in two phases.

Phase one 

In phase one of our project, we took a diagnostic system deep dive. For us to understand how practice varies between CCGs, we asked GPs, commissioners and cancer leads to tell us about their local diagnostic pathway. This report and its findings will be of crucial reading to the following stakeholders across England: 

  • Clinical Commissioning Groups
  • Integrated Care Systems
  • Cancer Alliances
  • Primary care professionals
  • Any organisation or persons responsible for the planning, implementation and use of ovarian cancer diagnostic pathways

To find out more about this work read the full report [PDF] or watch our animation to view the key findings from our research:

Phase two

Equipped with our research findings and resulting recommendations, we’re ready to launch phase two of our project – practical implementation. We’ll be working with Cancer Alliances and CCGs directly to develop and test interventions to promote early diagnosis.

Based on our research findings, we’ll be focusing on these four key areas:

  • using local level data to drive improvement
  • developing best practice for safety netting symptoms and the referral pathway
  • the role of technology in early diagnosis
  • support for GPs in readiness for the upcoming timed ovarian cancer pathway

If you have any questions about this project, or would like your organisation to work with us to create better care, everywhere, please email Natalie Ritrovato, Clinical Change Manager: commissioners@targetovariancancer.org.uk.

Target Ovarian Cancer would like to thank the Peter Sowerby Foundation whose kind generosity made this research possible. 

Peter Sowerby Foundation logo